Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis.
BACKGROUND: It is well known that the global population is aging and that those over the age of 80 are the fastest growing part of this expansion. Also known is that prevalence of hypertension and cognitive decline both increase with increasing age. METHOD: The Hypertension in the Very Elderly Trial...
المؤلفون الرئيسيون: | Peters, R, Beckett, N, Forette, F, Tuomilehto, J, Ritchie, C, Walton, I, Waldman, A, Clarke, R, Poulter, R, Fletcher, A, Bulpitt, C |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2009
|
مواد مشابهة
-
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.
حسب: Peters, R, وآخرون
منشور في: (2008) -
Fracture risk and the use of a diuretic (indapamide sr) ± perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET)
حسب: Thijs Lutgarde, وآخرون
منشور في: (2006-12-01) -
Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population use.
حسب: Ruth Peters, وآخرون
منشور في: (2010-07-01) -
Treatment of White Coat HYpertension in the Very Elderly Trial (HYVET 2) - Feasibility of a Randomized Controlled Trial (Study Protocol)
حسب: Michael Okorie, وآخرون
منشور في: (2019-11-01) -
HYVET Study results: importance for clinical practice
حسب: S. V. Nedogoda
منشور في: (2008-10-01)